Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260669 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260678 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-10 | 260687 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-19 | 2025-08-22 | 260690 |
| APO-LEVOTHYROXINE | 112MCG | TABLET | Resolved | 2025-06-19 | 2025-11-07 | 260693 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-20 | 2025-10-16 | 260817 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-31 | 260820 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-10 | 260823 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-07-03 | 2025-10-10 | 261632 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-07-03 | 2025-10-24 | 261641 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-16 | 262412 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-07-10 | 2025-11-14 | 262425 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-10 | 262429 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-08-14 | 2025-11-07 | 265284 |
| APO-LINEZOLID | 600MG | TABLET | Resolved | 2018-03-05 | 2019-11-04 | 41855 |
| APO-LINEZOLID | 600MG | TABLET TABLET | Resolved | 2022-05-13 | 2022-09-30 | 160607 |
| APO-LINEZOLID | 600MG | TABLET TABLET | Resolved | 2023-10-27 | 2023-11-10 | 208379 |
| APO-LISINOPRIL | 5MG | TABLET | Actual shortage | 2023-07-13 | 2025-01-30 | 198528 |
| APO-LISINOPRIL | 20MG | TABLET | Actual shortage | 2023-07-13 | 2024-04-05 | 198536 |
| APO-LISINOPRIL | 10MG | TABLET | Actual shortage | 2023-12-15 | 2024-04-05 | 213581 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247462 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247466 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-27 | 247469 |
| APO-AMITRIPTYLINE | 75MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-10 | 247472 |